Univariable analysis of predictor candidates by gender
| Variable | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|
| Control | CHD | T | p Value | Control | CHD | T | p Value | |
| (n=400) | (n=664) | (n=227) | (n=385) | |||||
| Age (year) | 45.5±12.1 | 62.2±11.0 | 23.02 | <0.001 | 43.3±10.4 | 64.9±9.0 | 26.02 | <0.001 |
| UA (µmol/L) | 404.9±86.1 | 375.4±96.8 | 5.16 | <0.001 | 282.6±61.3 | 325.7±87.9 | 7.12 | <0.001 |
| TC (mmol/L) | 4.9±0.9 | 4.6±1.1 | 5.94 | <0.001 | 4.5±0.8 | 5.0±1.3 | 5.78 | <0.001 |
| lnTG | 0.7±0.7 | 0.5±0.6 | 4.50 | <0.001 | 0.2±0.6 | 0.6±0.5 | 9.06 | <0.001 |
| HDL-C (mmol/L) | 1.3±0.4 | 1.1±0.3 | 10.75 | <0.001 | 1.6±0.3 | 1.2±0.3 | 12.61 | <0.001 |
| LDL-C (mmol/L) | 3.0±0.8 | 2.8±1.1 | 3.43 | 0.001 | 2.7±0.7 | 2.8±0.9 | 2.03 | 0.043 |
| apoA (g/L) | 1.5±0.3 | 1.2±0.3 | 15.31 | <0.001 | 1.6±0.2 | 1.3±0.2 | 14.22 | 0.009 |
| apoB (g/L) | 1.1±0.2 | 0.9±0.3 | 12.58 | <0.001 | 0.9±0.2 | 0.9±0.3 | 1.12 | <0.001 |
| lnLp(a) | 5.3±1.0 | 5.0±1.0 | 4.34 | <0.001 | 5.3±1.0 | 5.1±1.1 | 2.62 | <0.001 |
| lnHCY | 2.4±0.5 | 2.9±0.4 | 18.63 | <0.001 | 1.9±0.6 | 2.7±0.4 | 21.34 | <0.001 |
| lnTBil | 2.6±0.4 | 2.5±0.4 | 5.92 | <0.001 | 2.5±0.3 | 2.3±0.4 | 4.93 | <0.001 |
| lnDBil | 1.3±0.4 | 1.1±0.5 | 4.91 | <0.001 | 1.1±0.4 | 1.2±0.5 | 1.66 | 0.097 |
| lnIBil | 2.3±0.4 | 2.1±0.5 | 7.04 | <0.001 | 2.1±0.4 | 1.8±0.6 | 8.21 | <0.001 |
| lnGGT | 3.7±0.8 | 3.7±0.7 | 0.86 | 0.391 | 2.8±0.7 | 3.6±0.8 | 12.93 | <0.001 |
Normally distributed data were presented as means±SD, skewed data were logarithm transformed and presented as means±SD.
apoA, apolipoprotein A; apoB, apolipoprotein B; CHD, coronary heart disease; DBil, direct bilirubin; GGT, γ-glutamyl transpeptidase; HCY, homocysteine; HDL-C, high-density lipoprotein cholesterol; IBil, indirect bilirubin; LDL-C, low-density lipoprotein cholesterol; ln, logarithm transformed; Lp(a), lipoprotein(a); TBil, total bilirubin; TC, total cholesterol; TG, triglyceride; UA, uric acid.